Zai Lab gets China review for Pfizer-partnered cervical cancer therapy
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
koto_feja
- Zai Lab Limited (NASDAQ:ZLAB) announced Thursday that Chinese regulators accepted its marketing application for the cervical cancer therapy Tivdak developed in partnership with Pfizer (NYSE:PFE) unit Seagen.
- The company had submitted a Biologics License Application (BLA) for Tivdak with China???s National Medical